First up, we start by looking at the capital market. Over the past decade, China's innovative drug sector has attracted more than 1 trillion RMB in funding. For a strategic emerging industry like this, that kind of cash is like rocket fuel for innovation. And all that cash? It's paying...
Mainly driven by payers, RWE has influenced license (label), access, pricing, and use across countries and therapeutic areas (TAs). Approximately 25% of these decisions reflect industry-generated RWE, demonstrating that pharmaceutical companies influence this evolving landscape.RWE MARKET IMPACT RANKING...
When it comes to the development of new drugs as of January 2024, Swiss-based company Roche was the leader among the global top pharmaceutical companies. With 218 products in the R&D pipeline, Roche leads the ranking, closely followed by U.S. company Pfizer. Among the global top 15 companie...
Kelun Pharma achieved LVP sales revenue of Rmb9,451mn. We estimate that the Company has a market share of more than 30% in the LVP field. Kelun Pharma has kept adjusting the structure of its infusion products. The proportion of closed ...
27 The nature of the algorithms that influence the metrics that are used by pharma ranking systems to derive the ratings remains controversial;28 however, if observers deem the assessments that they provide to be trustworthy then regardless of what they are actually measuring, these platforms have ...
July 9, 2024 The bankrupt estate of Purdue Pharma says it will support a move by the opioid maker’s creditors to sue members of the Sackler family over allegations that they improperly shifted billions of dollars of Purdue profits into offshore trusts. The … ...
Niao Sai Tong Tablets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 Niasaitong Tablet is a traditional Chinese medicine preparation, mainly used to treat urinary tract symptoms caused by prostatic hyperplasia, such as frequent urination, urgent urination, painful urinatio...
Metaverse, Artificial Intelligence, Data Analytics, Machine Learning, Digitalization: these topics are ranking high on the agenda of the business leaders who understand the competitive advantages that can be seized by moving now into the future of this sector. Infomineo's presentation focuses on som...
It is one of the major business units in the healthcare sector of China Resources, ranking among the top 3 national pharmaceutical commercial enterprises. China Resource Pharma Comm primarily engages in pharmaceutical marketing, logistics distribution, and providing solutions for the pharmaceutical supply...
Capital Structure Market Cap $3.47M Total Debt $4.01M Cash $718.69K Other - Enterprise Value $6.76M Dividends CPHI does not currently pay a dividend. CPHI Ownership CPHI Peers Sorry, this data cannot be displayed at the moment. Technicals ...